Literature DB >> 18655215

Development and validation of HPLC method for imiquimod determination in skin penetration studies.

Daniel De Paula1, Carolina Azenha Martins, Maria Vitória Lopes Badra Bentley.   

Abstract

A simple, rapid and sensitive analytical procedure for the measurement of imiquimod in skin samples after in vitro penetration studies has been developed and validated. In vitro penetration studies were carried out in Franz diffusion cells with porcine skin. Tape stripping technique was used to separate the stratum corneum (SC) from the viable epidermis and dermis. Imiquimod was extracted from skin samples using a 7:3 (v/v) methanol:acetate buffer (100 mM, pH 4.0) solution and ultrasonication. Imiquimod was analyzed by HPLC using C(8) column and UV detection at 242 nm. The mobile phase used was acetonitrile:acetate buffer (pH 4.0, 100 mM):diethylamine (30:69.85:0.15, v/v) with flow rate 1 mL/min. Imiquimod eluted at 4.1 min and the running time was limited to 6.0 min. The procedure was linear across the following concentration ranges: 100-2500 ng/mL for both SC and tape-stripped skin and 20-800 ng/mL for receptor solution. Intra-day and inter-day accuracy and precision values were lower than 20% at the limit of quantitation. The recovery values ranged from 80 to 100%. The method is adequate to assay imiquimod from skin samples, enabling the determination of the cutaneous penetration profile of imiquimod by in vitro studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18655215     DOI: 10.1002/bmc.1075

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  9 in total

1.  Immunopotentiator-Loaded Polymeric Microparticles as Robust Adjuvant to Improve Vaccine Efficacy.

Authors:  Weifeng Zhang; Lianyan Wang; Tingyuan Yang; Yuan Liu; Xiaoming Chen; Qi Liu; Jilei Jia; Guanghui Ma
Journal:  Pharm Res       Date:  2015-05-28       Impact factor: 4.200

2.  A novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation.

Authors:  Tailane Sant'Anna Moreira; Valéria Pereira de Sousa; Maria Bernadete Riemma Pierre
Journal:  AAPS PharmSciTech       Date:  2010-04-07       Impact factor: 3.246

3.  Novel Fish Oil-based Bigel System for Controlled Drug Delivery and its Influence on Immunomodulatory Activity of Imiquimod Against Skin Cancer.

Authors:  Khurram Rehman; Mohd Hanif Zulfakar
Journal:  Pharm Res       Date:  2016-09-12       Impact factor: 4.200

4.  Preparation and Characterization of Naringenin-Loaded Elastic Liposomes for Topical Application.

Authors:  Ming-Jun Tsai; Yaw-Bin Huang; Jhih-Wun Fang; Yaw-Syan Fu; Pao-Chu Wu
Journal:  PLoS One       Date:  2015-07-09       Impact factor: 3.240

5.  Efficacy of imiquimod-based transcutaneous immunization using a nano-dispersed emulsion gel formulation.

Authors:  Pamela Stein; Karsten Gogoll; Stefan Tenzer; Hansjörg Schild; Stefan Stevanovic; Peter Langguth; Markus P Radsak
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

6.  Models and methods to characterise levonorgestrel release from intradermally administered contraceptives.

Authors:  Adnan Al Dalaty; Benedetta Gualeni; Sion A Coulman; James C Birchall
Journal:  Drug Deliv Transl Res       Date:  2021-12-03       Impact factor: 4.617

7.  A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice.

Authors:  Humzah Jamshaid; Fakhar Ud Din; Maimoona Malik; Muhammad Mukhtiar; Han Gon Choi; Tofeeq Ur-Rehman; Gul Majid Khan
Journal:  Sci Rep       Date:  2022-08-20       Impact factor: 4.996

8.  Liposomes can both enhance or reduce drugs penetration through the skin.

Authors:  Ma F Peralta; Ma L Guzmán; A P Pérez; G A Apezteguia; Ma L Fórmica; E L Romero; Ma E Olivera; D C Carrer
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

9.  Assessing the Dermal Penetration Efficacy of Chemical Compounds with the Ex-Vivo Porcine Ear Model.

Authors:  Cornelia M Keck; Ayat Abdelkader; Olga Pelikh; Sabrina Wiemann; Vasudha Kaushik; David Specht; Ralph W Eckert; Reem M Alnemari; Henriette Dietrich; Jana Brüßler
Journal:  Pharmaceutics       Date:  2022-03-19       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.